207 related articles for article (PubMed ID: 21425790)
1. Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.
Mullen DG; McNerny DQ; Desai A; Cheng XM; Dimaggio SC; Kotlyar A; Zhong Y; Qin S; Kelly CV; Thomas TP; Majoros I; Orr BG; Baker JR; Banaszak Holl MM
Bioconjug Chem; 2011 Apr; 22(4):679-89. PubMed ID: 21425790
[TBL] [Abstract][Full Text] [Related]
2. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
3. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
Yue Y; Eun JS; Lee MK; Seo SY
Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells.
Shi X; Wang SH; Lee I; Shen M; Baker JR
Biopolymers; 2009 Nov; 91(11):936-42. PubMed ID: 19603491
[TBL] [Abstract][Full Text] [Related]
6. The facile synthesis of multifunctional PAMAM dendrimer conjugates through copper-free click chemistry.
Huang B; Kukowska-Latallo JF; Tang S; Zong H; Johnson KB; Desai A; Gordon CL; Leroueil PR; Baker JR
Bioorg Med Chem Lett; 2012 May; 22(9):3152-6. PubMed ID: 22480432
[TBL] [Abstract][Full Text] [Related]
7. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
8. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.
Wong PT; Choi SK
Int J Mol Sci; 2015 Jan; 16(1):1772-90. PubMed ID: 25590303
[TBL] [Abstract][Full Text] [Related]
10. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
11. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
[TBL] [Abstract][Full Text] [Related]
12. Fluorogenic 'click-on' dendrimer reporter for rapid profiling of cell proliferation.
Goonewardena SN; Leroueil PR; Gemborys C; Tahiliani P; Emery S; Baker JR; Zong H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2230-3. PubMed ID: 23434421
[TBL] [Abstract][Full Text] [Related]
13. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer.
Choi Y; Baker JR
Cell Cycle; 2005 May; 4(5):669-71. PubMed ID: 15846063
[TBL] [Abstract][Full Text] [Related]
15. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
[TBL] [Abstract][Full Text] [Related]
16. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.
Choi SK; Thomas T; Li MH; Kotlyar A; Desai A; Baker JR
Chem Commun (Camb); 2010 Apr; 46(15):2632-4. PubMed ID: 20449327
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
18. Negative dendritic effect on enzymatic hydrolysis of dendrimer conjugates.
Zhou Z; Cong M; Li M; Tintaru A; Li J; Yao J; Xia Y; Peng L
Chem Commun (Camb); 2018 Jun; 54(47):5956-5959. PubMed ID: 29799034
[TBL] [Abstract][Full Text] [Related]
19. A "click chemistry" approach to the efficient synthesis of multiple imaging probes derived from a single precursor.
Mindt TL; Müller C; Stuker F; Salazar JF; Hohn A; Mueggler T; Rudin M; Schibli R
Bioconjug Chem; 2009 Oct; 20(10):1940-9. PubMed ID: 19803478
[TBL] [Abstract][Full Text] [Related]
20. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
